Crinetics Pharma Files Definitive Proxy Statement
Ticker: CRNX · Form: DEFA14A · Filed: May 20, 2025 · CIK: 1658247
| Field | Detail |
|---|---|
| Company | Crinetics Pharmaceuticals, Inc. (CRNX) |
| Form Type | DEFA14A |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
Related Tickers: CRNX
TL;DR
CRNX proxy filing is out - shareholders vote soon on company matters.
AI Summary
Crinetics Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEFA14A) on May 20, 2025. This filing is an amendment to previous materials and concerns the solicitation of proxies for its annual meeting. The company is based in San Diego, California, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the company's annual meeting, influencing their voting decisions on corporate governance and strategic matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial or operational risks.
Key Players & Entities
- Crinetics Pharmaceuticals, Inc. (company) — Registrant
- 0000950170-25-074707 (filing_id) — Accession Number
- 20250520 (date) — Filing Date
- 20250519 (date) — Date as of Change
- San Diego, CA (location) — Business Address
FAQ
What type of SEC filing is this?
This is a Definitive Proxy Statement (DEFA14A) filed by Crinetics Pharmaceuticals, Inc.
When was this filing submitted?
The filing was submitted on May 20, 2025.
What is the company's primary business?
Crinetics Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations industry (SIC code 2834).
Where is Crinetics Pharmaceuticals, Inc. located?
The company's business address is 6055 Lusk Blvd., San Diego, CA 92121.
Is this a preliminary or definitive proxy statement?
This is a Definitive Proxy Statement, indicated by the checkmark next to 'Definitive Proxy Statement' and 'Definitive Additional Materials'.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 20, 2025 regarding Crinetics Pharmaceuticals, Inc. (CRNX).